Accretion Nutraveda (BOM:544694) ROCE %: 29.47% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544694 Accretion Nutraveda Ltd BOM:544694
21 GF Score
Price ₹283.95
! 3 Warning Signs
View Full Analysis

What is Accretion Nutraveda ROCE %?

Accretion Nutraveda BOM:544694 21 ROCE % is 29.47% as of Mar. 2026. GuruFocus rates BOM:544694 with a GF Score™ of 21/100. The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Accretion Nutraveda's annualized ROCE % for the quarter that ended in Mar. 2026 was 29.47%.

Accretion Nutraveda  (BOM:544694) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Accretion Nutraveda ROCE % Related Terms

Accretion Nutraveda ROCE % Historical Data

* Premium members only.

The historical data trend for Accretion Nutraveda's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accretion Nutraveda ROCE % Chart

Accretion Nutraveda Annual Data
Trend Mar23 Mar24 Mar25 Mar26
ROCE %
27.19 69.85 82.40 29.22

Accretion Nutraveda Semi-Annual Data
Mar23 Mar24 Mar25 Sep25 Mar26
ROCE % 0.00 0.00 115.92 77.13 29.47
BOM:544694
21GF Score
Accretion Nutraveda Ltd BOM:544694
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Accretion Nutraveda ROCE % Calculation

Accretion Nutraveda's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=67.456/( ( (108.622 - 39.513) + (417.938 - 25.39) )/ 2 )
=67.456/( (69.109+392.548)/ 2 )
=67.456/230.8285
=29.22 %

Accretion Nutraveda's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=71.46/( ( (163.494 - 71.055) + (417.938 - 25.39) )/ 2 )
=71.46/( ( 92.439 + 392.548 )/ 2 )
=71.46/242.4935
=29.47 %

(1) Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 29.47% mean?
Accretion Nutraveda (BOM:544694) has a ROCE % of 29.47% as of Mar. 2026.
Is Accretion Nutraveda's ROCE % too high?
Accretion Nutraveda's current ROCE % is 29.47%. The Drug Manufacturers industry median ROCE % is 7.03. Accretion Nutraveda's value of 29.47% is 319.2% above this industry median. Overall, Accretion Nutraveda has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Accretion Nutraveda's ROCE % compare to ZTS?
Accretion Nutraveda's ROCE % of 29.47% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.03. Accretion Nutraveda's value of 29.47% is 319.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.03, based on 963 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Accretion Nutraveda's current ROCE % of 29.47% is 319.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Accretion Nutraveda's current ROCE % is 29.47%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accretion Nutraveda stock overvalued right now?
Accretion Nutraveda (BOM:544694) has a current ROCE % of 29.47%. The current ROCE % is 29.47% and 319.2% above the Drug Manufacturers industry median of 7.03. Accretion Nutraveda's overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Accretion Nutraveda (BOM:544694), the current ROCE % is 29.47% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Accretion Nutraveda Business Description

Address 27 Xcelon Industrial Park-1, Vasna-Chacharwadi, Taluka Sanand, Ahmedabad, GJ, IND, 382213
Accretion Nutraveda Ltd is engaged in the business of the Manufacturing of Ayurvedic and Nutraceutical products across several dosage forms, including Tablets, Capsules, Oral liquids, Oral Powders, External Preparation and Oils. It is a healthcare focused Company specializing in contract manufacturing, serving domestic as well as export markets in various countries like Sri Lanka, Singapore and the USA. The company offers a diverse range of dosage forms, leveraging both Classical Ayurvedic principles and modern nutraceutical science. Its product portfolio includes Tablets, such as film-coated and chewable varieties, for applications in liver care, gynecological care, bone and joint health, and respiratory support.
21GF Score

Get the complete analysis for BOM:544694

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹283.95
Price